Herbas VPB

Spausdinti
EN | LT
LT - ENANTIOMERS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHANAMINE (ANAVEX2-73) AND USE THEREOF IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER DISORDERS MODULATED BY THE SIGMA 1 RECEPTOR
EN - ENANTIOMERS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHANAMINE (ANAVEX2-73) AND USE THEREOF IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER DISORDERS MODULATED BY THE SIGMA 1 RECEPTOR

Teisinis statusas

Patentas neįsigaliojo (pagal EPK)

Bibliografiniai duomenys
Tarptautinės patentų klasifikacijos indeksai (TPK)
(51) INT.CL. A61K 31/341 (2006.01)
C07D 231/22 (2013.01)
A61P 25/28 (2006.01)
G01N 33/5005 (2013.01)
C07D 307/14 (2006.01)
A61K 31/341 (2013.01)
G01N 33/567 (2006.01)
A61P 25/28 (2018.01)
Europos patentas
(11) Patento numeris 3324956
(13) Dokumento rūšis T
(96) Europos patento paraiškos numeris 16827322.5
Europos patento paraiškos padavimo data 2016-07-19
(97) Europos patento paraiškos paskelbimo data 2018-05-30
(45) Paskelbimo apie Europos patento išdavimą data 2024-11-20
(46) Apibrėžties vertimo paskelbimo data
Tarptautinės paraiškos padavimo
(86) Numeris PCT/IB2016/001158
Data 2016-07-19
Tarptautinės paraiškos paskelbimo
(87) Numeris WO 2017/013496
Data 2017-01-26
Prioriteto paraiškos
(30) Numeris Data Šalis
201562195417 P 2015-07-22 US
Išradėjai
(72)
NELIAT, Gervais , US
Savininkas
(73) Anavex Life Sciences Corp. , 51 West 52nd Street 7th Floor, New York, NY 10019, US
Pavadinimas
(54) ENANTIOMERS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHANAMINE (ANAVEX2-73) AND USE THEREOF IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER DISORDERS MODULATED BY THE SIGMA 1 RECEPTOR
  ENANTIOMERS OF TETRAHYDRO-N,N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHANAMINE (ANAVEX2-73) AND USE THEREOF IN THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER DISORDERS MODULATED BY THE SIGMA 1 RECEPTOR